CD8A and non-Hodgkin lymphoma: Moreover, there was a substantial difference in percentages of PD-1+CD20+ and PD-1+CD3+CD8+ cells between NHL patients and normal controls (median = 8.0 vs. 0.7 and 5.0 vs. 0.45, respectively; p < 0.001).